© Reuters. FILE PHOTO: Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken November 27, 2021. REUTERS/Dado Ruvic/Illustration
NEW YORK (Reuters) – Vaccine maker Moderna (NASDAQ:) Inc’s chief commercial officer (CCO) said on Thursday that the size of the future COVID-19 vaccine market in the United States could be in the range of $5.2 billion to $12.9 billion, depending on the price of shots and who is eligible to receive them.
Globally, the company said the size of the high-risk population that would be eligible for the shots is around 340 million people, Moderna CCO Arpa Garay said, speaking at the company’ annual reseacrh and development event.
Be the first to comment